Dew... Thank you for the comment. One follow-up question I have is won't GTCB potentially need to raise some capital in mid-to-late FY 2008 (assuming it splits the cost of research/clinical trials with a partner) and wouldn't it be easiest and most beneficial if the equity was raised through a partner? But, then again who knows what the partnership terms will end up looking like.
Market Data 
Markets 
AI
